US 7601709
Macrocyclic hepatitis C serine protease inhibitors
granted A61KA61K38/12A61P
Quick answer
US patent 7601709 (Macrocyclic hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 75
- CPC classes
- A61K, A61K38/12, A61P, A61P31/12